High doses of CCL3L1 could affect HIV-1 infection either by (1) inhibiting HIV-1 gp120 binding to CCR5; (2) reducing CCR5 levels at the cell-surface due to receptor internalization; or (3) affecting leukocyte trafficking important for antiviral responses. The gene discussed is CCR5; the disease is HIV-1 infection.